Isolated IgA deficiency after chemotherapy for acute myelogenous leukemia in an infant

Pediatric Hematology and Oncology

Volumn 20, Issue 6, 2003, Pages 487-492

  Uram, Rebecca ^a   Rosoff, Philip M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute myelogenous leukemia; AML; IgA deficiency; Immunodeficiency; Late effects

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TENIPOSIDE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; FEVER; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; INFANT; INFANT DISEASE; INFECTION; LYMPHOCYTOPENIA; NEUTROPENIA;

EID: 0042427756     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/0888001039022017     Document Type: Article

References (23)

1. Woods WG, Kobrinsky N, Buckley JD, et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the children's cancer group. Blood. 1996;87:4976-4989.
2. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood. 2001;97:56-62.
3. Trigg ME. Can we make some general recommendations regarding immune recovery after hematopoietic reconstitution preceded by ablative therapy? Pediatr Transplant. 1999;3(Suppl 1):45-51.
4. King SM, Saunders EF, Petric M, et al. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant. 1996;17:633-636.
5. Feldman S, Andrew M, Norris M, et al. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia. Clin Infect Dis. 1998;27:388-390.
6. Ridgway D, Wolff LJ. Active immunization of children with leukemia and other malignancies. Leuk Lymphoma. 1993;9:177-192.
7. Abrahamsson J, Marky I, Mellander L. Immunoglobulin levels and lymphocyte response to mitogenic stimulation in children with malignant disease during treatment and follow-up. Acta Paediatr. 1995;84:177-182.
8. Alsabti EA. Serum immunoglobulins in acute myelogenous leukemia. Neoplasma. 1979;26:611-615.
9. Caver TE, Slobod KS, Flynn PM, et al. Profound abnormality of the b/t lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia. Leukemia. 1998;12:619-622.
10. Gause A, Schmitz G, von Kalle AK, et al. The clinical relevance of igg subclasses in acute leukemias: low serum igg as a risk factor for early death due to infection in acute myelogenous leukemia. Leuk Res. 1992;16:165-171.
11. Nilsson A, De Milito A, Engstrom P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics. 2002;109:e91.
12. Spickermann D, Gause A, Pfreundschuh M, et al. Impaired antibody levels to tetanus toxoid and pneumococcal polysaccharides in acute leukemias. Leuk Lymphoma. 1994;16:89-96.
13. Pasino M, Vadala CR, De Bernardi B, et al. Immunological evaluation of 22 patients with acute lymphoblastic leukemia off-therapy: a longitudinal follow-up. Helv Paediatr Acta. 1981;36:69-80.
14. de Vaan GA, van Munster PJ, Bakkeren JA. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (all) of childhood. Eur J Pediatr. 1982;139:113-117.
15. Zandvoort A, Lodewijk ME, Klok PA, et al. Slow recovery of follicular b cells and marginal zone b cells after chemotherapy: implications for humoral immunity. Clin Exp Immunol. 2001;124:172-179.
16. Bernstein JA, Garramone SM, Lower EG. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Ann Allergy Asthma Immunol. 2002;89:212-214.
17. Khalifa AS, Take H, Cejka J, et al. Immunoglobulins in acute leukemia in children. J Pediatr. 1974;85:788-791.
18. Kristinsson VH, Kristinsson JR, Jonmundsson GK, et al. Immunoglobulin class and subclass concentrations after treatment of childhood leukemia. Pediatr Hematol Oncol. 2001;18:167-172.
19. Nussinson E, Lahav M, Berebi A, et al. Secretory piece and IgA deficiency in a patients with Waldenstrom's macroglobulinemia. Am J Gastroenterol. 1986;81:995-998.
20. Yoo EM, Coloma MJ, Trinh KR, et al. Structural requirements for polymeric immunoglobulin assembly and association with j chain. J Biol Chem. 1999;274:33771-33777.
21. Rojas R, Apodaca G. Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol. 2002;3:944-955.
22. Fallgreen-Gebauer E, Gebauer W, Bastian A, et al. The covalent linkage of secretory component to IgA: structure of siga. Biol Chem Hoppe-Seyler. 1993;374:1023-1028.
23. Monteiro RC, Van De Winkel JG. IgA fc receptors. Annu Rev Immunol. 2003;21:177-204.